IMMUNOTECHNOLOGY CORP 4
4 · IMMUNOTECHNOLOGY CORP · Filed Jul 5, 2006
Insider Transaction Report
Form 4
SCHARMANN MARK A
Director
Transactions
- Other
Common Stock
2006-06-30$0.20/sh+42,477$8,495→ 2,789,855 total
Holdings
- 33,750(indirect: By IRA)
Common Stock
- 725(indirect: Shares held by Troika Capital, Inc., an entity controlled by the Reporting Person)
Common Stock